MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD‐associated NSCLC
Abstract Background Patients with non‐small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) experience worse clinical outcomes but respond better to immunotherapy than patients with NSCLC without COPD. Mucosal‐associated invariant T (MAIT) cells, a versatile population of i...
Main Authors: | Yanze Yin, Ao Zeng, Abudumijiti Abuduwayiti, Zhilong Xu, Keyi Chen, Chao Wang, Xinyun Fang, Jiarui Wang, Gening Jiang, Jie Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.7112 |
Similar Items
-
Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD)
by: Ao Zeng, et al.
Published: (2024-03-01) -
MAIT Cell Activation and Functions
by: Timothy S. C. Hinks, et al.
Published: (2020-05-01) -
MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors
by: Ali Amini, et al.
Published: (2020-11-01) -
MicroRNA-155 Regulates MAIT1 and MAIT17 Cell Differentiation
by: Tingting Liu, et al.
Published: (2021-04-01) -
Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease
by: Yujue Zhang, et al.
Published: (2021-07-01)